← Leaderboards
Thomas A Owen
Cayman Chemical Company, Inc.
$850,243
Attributed
$1,700,486
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $906.7K · FY2021–22$1M$750K$500K$250K$0
'21
'22
Funding mix
By agency
NIH$1,700,486 · 1
By mechanism
R44$1,700,486 · 1
Top collaborators
- Maria Ines Morano2 shared
Most similar at Cayman Chemical Company, Inc.
Same institution · by research overlap
- Stephen Douglas Barrett$1,478,369
- Daniel Bochar$224,852
- Paul Douglas Kennedy$306,868
Others in their field
Other Emerging Leaders on “Acceleration”
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$96,326,191
- Terry Drinkwine · Carahsoft Technology Corporation$93,741,163
- Mark Marino · Venturewell$61,502,138
- Klaus Romero · Critical Path Institute$58,665,332
Research focus
AccelerationAgonistAlveolar RidgeAnabolic AgentsBiologicalBiomechanicsBoneBone DensityBone RegenerationBone StrengthCalvariaCaymansCellsClinical ResearchCollagenDefectDentalDental ImplantsDentistsDesignDevicesDoseEdentulism3-Dimensional